Drug profile · INN
sevoflurane
ULTANE
- US status
- approved
- Patents linked
- 6
- News articles
- 0
Quick answer
sevoflurane (ULTANE) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 11061094
Simultaneous pH and oxygen weighted MRI contrast using multi-echo chemical exchange saturation transfer imaging (ME-CEST)
granted -
US 9119828
Antibodies with simultaneous subsite specificities to protein and lipid epitopes
granted -
US 8691967
Multiple promoter expression cassettes for simultaneous delivery of RNAi agents
granted -
US 8283461
Multiple promoter expression cassettes for simultaneous delivery of RNAi agents
granted -
US 7727970
Multiple promoter expression cassettes for simultaneous delivery of RNAi agents targeted to Hepatitis C virus
granted -
US 7572124
Apparatus for simultaneous illumination of teeth
granted
Frequently asked questions
What is sevoflurane?
sevoflurane (ULTANE) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.
What is the brand name for sevoflurane?
ULTANE is a marketed brand name for sevoflurane. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sevoflurane?
sevoflurane has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.